Clinical Trial Update: Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating high-dose PURETHAL mite extract for allergic rhinitis and allergic rhinoconjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Allergic Rhinoconjunctivitis

Drugs mentioned

• PURETHAL Mites (house dust mite extract)

Snippet

Sponsor: HAL Allergy | Conditions: Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 2 | Status: COMPLETED